Anavex Life Sciences Corp (AVXL)

[kevindenver]

So true and disappointing. The theories of clearing amyloid plaques as the answer has failed. Now is the time to move on to new theories such as mitochondrial disfunction and restoring cellular homeostasis and reducing inflammation. The timing is ripe for blarcamesine to prove out it's MOA in both Rett Syndrome and AD and shortly thereafter Parkinson's disease and it's dementia.

"The scientific community has essentially finished with
amyloid - we've identified it, developed drugs, and can clear it,